This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Atyr Pharma, Inc.. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: The Innovative Contributions of Ji Zhao
Introduction
Ji Zhao is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of tRNA synthetases with non-canonical biological activities. With a total of 5 patents, his work has the potential to impact various applications in medicine and biotechnology.
Latest Patents
Ji Zhao's latest patents include groundbreaking compositions and methods involving aspartyl-tRNA synthetases and glycyl-tRNA synthetases. His patent on "Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities" provides isolated aspartyl-tRNA synthetase polypeptides and polynucleotides, along with related compositions and methods. Additionally, his patent titled "Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities" offers isolated glycyl-tRNA synthetase polypeptides and polynucleotides, as well as associated compositions and methods.
Career Highlights
Ji Zhao is currently associated with Atyr Pharma, Inc., where he continues to advance his research and innovations. His work at Atyr Pharma focuses on leveraging his expertise in tRNA synthetases to develop novel therapeutic strategies.
Collaborations
Throughout his career, Ji Zhao has collaborated with notable colleagues, including Leslie Ann Greene and Ryan Andrew Adams. These collaborations have fostered a dynamic research environment, enhancing the potential for innovative discoveries.
Conclusion
Ji Zhao's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
